Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06XSB
|
||||
| Former ID |
DIB010315
|
||||
| Drug Name |
870086 (topical, atopic dermatitis), GlaxoSmithKline
|
||||
| Synonyms |
GW-870086-X (topical, atopic dermatitis), GlaxoSmithKline
|
||||
| Company |
GlaxoSmithKline plc
|
||||
| Target and Pathway | |||||
| Target(s) | Glucocorticoid receptor | Target Info | Agonist | [532254] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| References | |||||
| Ref 522149 | ClinicalTrials.gov (NCT00549497) A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers. U.S. National Institutes of Health. | ||||
| Ref 523364 | ClinicalTrials.gov (NCT01299610) A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.